Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
229M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
43.6K
-
Shares change
-
-16K
-
Total reported value, excl. options
-
$73.5K
-
Value change
-
-$25.2K
-
Number of sells
-
-2
-
Price
-
$1.69
Significant Holders of Lineage Cell Therapeutics, Inc. - Common (LCTX) as of Q3 2025
8 filings reported holding LCTX - Lineage Cell Therapeutics, Inc. - Common as of Q3 2025.
Lineage Cell Therapeutics, Inc. - Common (LCTX) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.6K shares
of 229M outstanding shares and own 0.02% of the company stock.
Largest 8 shareholders include CHAPIN DAVIS, INC. (20K shares), AssuredPartners Investment Advisors, LLC (16.5K shares), Pacifica Partners Inc. (2.93K shares), CWM, LLC (2.54K shares), TRUST CO OF VERMONT (1.55K shares), Farther Finance Advisors, LLC (84 shares), Sound Income Strategies, LLC (4 shares), and ST GERMAIN D J CO INC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.